A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab.

MLA

Passariello, Margherita, et al. “A Novel Human Neutralizing MAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab.” International Journal of Molecular Sciences, vol. 23, no. 10, May 2022. EBSCOhost, https://doi.org/10.3390/ijms23105556.

APA

Passariello, M., Ferrucci, V., Sasso, E., Manna, L., Lembo, R. R., Pascarella, S., Fusco, G., Zambrano, N., Zollo, M., & De Lorenzo, C. (2022). A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab. International Journal of Molecular Sciences, 23(10). https://doi.org/10.3390/ijms23105556

Chicago

Passariello, Margherita, Veronica Ferrucci, Emanuele Sasso, Lorenzo Manna, Rosa Rapuano Lembo, Stefano Pascarella, Giovanna Fusco, Nicola Zambrano, Massimo Zollo, and Claudia De Lorenzo. 2022. “A Novel Human Neutralizing MAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab.” International Journal of Molecular Sciences 23 (10). doi:10.3390/ijms23105556.